Join to View Full Profile
4301 W Markham St# 508Little Rock, AR 72205
Phone+1 501-296-1200
Fax+1 501-603-1550
Dr. Yadala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Vivek Yadala is an Oncologist based in Little Rock, AR, specializing in Hematologic-oncology.
He completed Internship year at the University of Arkansas for Medical Sciences, followed by a residency in internal medicine at Marshall University School of Medicine. He graduated in 2012 from BLDE University - Medical College.
Dr. Yadala has authored multiple publications, including research on immunotherapy-induced sarcoid-like reactions and a case report on breast cancer with Birt-Hogg-Dubé syndrome.
His work in neurobiology and neurology, particularly on intraventricular hemorrhage in preterm newborns, has received notable citations.
Education & Training
BLDE University - Medical CollegeClass of 2012
University of Arkansas for Medical Sciences (UAMS) College of MedicineInternship, Transitional Year
Marshall University School of MedicineResidency, Internal Medicine
Certifications & Licensure
AR State Medical License 2023 - 2026
OH State Medical License 2021 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsImmunotherapy-Induced Sarcoid-Like Reaction: A Shrewd Imitator:Hassaan Yasin, Vivek Yadala, Noman Ahmed Jang Khan, Vincent Graffeo, Krista L. Denning
Journal of Investigative Medicine High Impact Case Reports. 2021-04-13 - Breast cancer in a patient with Birt-Hogg-Dubé syndrome (BHDS) with dramatic response to neoadjuvant chemotherapyVivek Yadala, Hassaan Jafri, Mary T Legenza, Maria Tria Tirona
BMJ Case Reports. 2020-02-01 - 27 citationsGlycogen synthase kinase-3β inhibition enhances myelination in preterm newborns with intraventricular hemorrhage, but not recombinant Wnt3A.Preeti Dohare, Bokun Cheng, Ehsan Ahmed, Vivek Yadala, Pranav Singla
Neurobiology of Disease. 2018-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
